Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).

Stadler WM, Swerdloff JN, Margolin K, McCulloch B, Thompson J. A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC). J Clin Oncol. 2005 Jun; 23(16_suppl):4669.

View in: PubMed

collapse authors with profiles